Hyundai Pharmaceutical Co., Ltd. 004310.KS Stock
Hyundai Pharmaceutical Co., Ltd. Price Chart
Hyundai Pharmaceutical Co., Ltd. 004310.KS Financial and Trading Overview
Hyundai Pharmaceutical Co., Ltd. stock price | 3765 KRW |
Previous Close | 4180 KRW |
Open | 4190 KRW |
Bid | 4200 KRW x 0 |
Ask | 4205 KRW x 0 |
Day's Range | 4150 - 4240 KRW |
52 Week Range | 3780 - 6940 KRW |
Volume | 91.7K KRW |
Avg. Volume | 207.63K KRW |
Market Cap | 115.78B KRW |
Beta (5Y Monthly) | 0.860694 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 KRW |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | December 28, 2022 |
1y Target Est | N/A |
004310.KS Valuation Measures
Enterprise Value | 111.56B KRW |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 1.070679 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 1.032 |
Enterprise Value/EBITDA | 25.958 |
Trading Information
Hyundai Pharmaceutical Co., Ltd. Stock Price History
Beta (5Y Monthly) | 0.860694 |
52-Week Change | -5.0000012% |
S&P500 52-Week Change | 20.43% |
52 Week High | 6940 KRW |
52 Week Low | 3780 KRW |
50-Day Moving Average | 4929.1 KRW |
200-Day Moving Average | 4864.78 KRW |
004310.KS Share Statistics
Avg. Volume (3 month) | 207.63K KRW |
Avg. Daily Volume (10-Days) | 234.76K KRW |
Shares Outstanding | 27.53M |
Float | 16.84M |
Short Ratio | N/A |
% Held by Insiders | 24.38% |
% Held by Institutions | 1.12% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | N/A |
Trailing Annual Dividend Yield | N/A |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 10:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | November 30, 2013 |
Most Recent Quarter (mrq) | November 30, 2013 |
Next Fiscal Year End | November 30, 2014 |
Profitability
Profit Margin | 1.30% |
Operating Margin (ttm) | 2.02% |
Gross Margin | 37.44% |
EBITDA Margin | 3.97% |
Management Effectiveness
Return on Assets (ttm) | 0.93% |
Return on Equity (ttm) | 1.45% |
Income Statement
Revenue (ttm) | 108.14B KRW |
Revenue Per Share (ttm) | 4611.46 KRW |
Quarterly Revenue Growth (yoy) | 5.00% |
Gross Profit (ttm) | 40.49B KRW |
EBITDA | 4.3B KRW |
Net Income Avi to Common (ttm) | 1.41B KRW |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 14.63B KRW |
Total Cash Per Share (mrq) | 623.91 KRW |
Total Debt (mrq) | 20.75B KRW |
Total Debt/Equity (mrq) | 20.5 KRW |
Current Ratio (mrq) | 2.196 |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | 7.95B KRW |
Levered Free Cash Flow (ttm) | 6.29B KRW |
Profile of Hyundai Pharmaceutical Co., Ltd.
Country | South Korea |
State | N/A |
City | Seoul |
Address | Hyundai Pharm Building |
ZIP | 06121 |
Phone | N/A |
Website | https://www.hyundaipharm.co.kr |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical equipment in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antianginal, antibiotic, antiemetics+antinauseants, antihistamines and antiallergics, antihyperlipidemic, antihypertensive, antiplatelet agent, antitussives, cell stimulants and proliferants, central nervous system, depilatory, dermatological agent, dermatology, dietary supplements, digestive system, endocrine system, expectorants, eye tonic and eye vitamins, gynaecolog antifungals, gynaecologic antiseptics, hemostatics, labour inhibitors, leukotriene modulator, narcotic analgesics, NSAIDs, oestrogens, ophthalmic products, OTH.sex horm and similar, SERMS, systemic hormonal contraceptives, urogenital system depilatory, uterotonic products, various alimentary tract and metabolism products, vitamins, acne, allergy, alopecia treatment, analgesics and anti-inflammatory, anemia, antimicrobial and antivirus, arthritis, contraceptives, dermatological agent, diagnostic reagent, gastrointestinal disorder and digestant, lip care, nutrition, ophthalmic product, respiratory, urogenital system, wound healing, and others. The company was founded in 1965 and is headquartered in Seoul, South Korea.
Q&A For Hyundai Pharmaceutical Co., Ltd. Stock
What is a current 004310.KS stock price?
Hyundai Pharmaceutical Co., Ltd. 004310.KS stock price today per share is 3765 KRW.
How to purchase Hyundai Pharmaceutical Co., Ltd. stock?
You can buy 004310.KS shares on the KSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hyundai Pharmaceutical Co., Ltd.?
The stock symbol or ticker of Hyundai Pharmaceutical Co., Ltd. is 004310.KS.
Which industry does the Hyundai Pharmaceutical Co., Ltd. company belong to?
The Hyundai Pharmaceutical Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Hyundai Pharmaceutical Co., Ltd. have in circulation?
The max supply of Hyundai Pharmaceutical Co., Ltd. shares is 26.81M.
What is Hyundai Pharmaceutical Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Hyundai Pharmaceutical Co., Ltd. PE Ratio is now.
What was Hyundai Pharmaceutical Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Hyundai Pharmaceutical Co., Ltd. EPS is 0 KRW over the trailing 12 months.
Which sector does the Hyundai Pharmaceutical Co., Ltd. company belong to?
The Hyundai Pharmaceutical Co., Ltd. sector is Healthcare.